Ms. Linda Joyce Caiger, R.N., I.B.C.L.C. Registered Nurse - Lactation Consultant Medicare: Not Enrolled in Medicare Practice Location: 8 Estate Hull, St. Thomas, VI 00802 Phone: 340-774-6867 |
Ms. Ophelia Alvina Torres, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 6501 Red-hook Plaza # 201, Fortress Mall; Building K. Unit 2009, St. Thomas, VI 00802 Phone: 340-774-8889 Fax: 340-774-3447 |
Gregory Bowen, RN Registered Nurse - Infusion Therapy Medicare: Not Enrolled in Medicare Practice Location: 2 Honduras, St. Thomas, VI 00802 Phone: 340-727-0220 |
Ms. Jamila Jacintha Connor, RN Registered Nurse - Critical Care Medicine Medicare: Not Enrolled in Medicare Practice Location: Schneider Regional Medical Center, 9048 Sugar Estate, St. Thomas, VI 00803 Phone: 340-776-8311 |
Jacqueline Davis, Registered Nurse - Psych/Mental Health Medicare: Not Enrolled in Medicare Practice Location: Barbel Plaza South, First Floor, Ross Building, St. Thomas, VI 00802 Phone: 340-774-7700 |
Mrs. Stephanie Torres-acuna, RN Registered Nurse Medicare: Accepting Medicare Assignments Practice Location: 9053 Estate Thomas, Suite 106, St. Thomas, VI 00802 Phone: 340-777-6423 Fax: 800-980-8620 |
News Archive
BDI Pharma, Inc. (BDI), the fastest growing national distributor of biotech therapies, announced today the introduction of SecuriVAX(SM) (www.securivax.com), an online supply solution providing the healthcare community a one-stop source for a wide variety of vaccines.
Peripheral artery disease develops silently, narrowing blood vessels for decades until the supply of nutrients and oxygen falls low enough to cause cramps and leg pain.
Neuren Pharmaceuticals Ltd (Neuren) and Metabolic Pharmaceuticals Ltd (Metabolic) have announced that the two companies have agreed to collaborate to co-develop Neuren's class of Neuro-regenerative Peptides (NRPs) for the treatment of degenerative conditions such as peripheral neuropathy, motor neuron disease and repairing the brain or nerves after injuries such as spinal cord injury.
A new study has characterized and compared the N-glycosylation of the wild type (S-614D) and variant (S-614G) of SARS-CoV-2 S glycoproteins using MS techniques.
› Verified 9 days ago